References

10.3322/caac.70090

10.3322/caac.70090 · External reference

10.1016/j.remnie.2024.500080

10.1016/j.remnie.2024.500080 · External reference

Clinical implication of FDG uptake of bone marrow on PET/CT in gastric cancer patients with surgical resection

10.3748/wjg.v23.i13.2385 · 2017 · External reference

18F-FDG PET/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma

10.1186/s40644-020-00313-2 · 2020 · External reference

[18F]FDG uptake of bone marrow on PET/CT for predicting distant recurrence in breast cancer patients after surgical resection

10.1186/s13550-020-00660-y · 2020 · External reference

Prognostic significance of bone marrow and spleen 18F-FDG uptake in patients with colorectal cancer

10.1038/s41598-021-91608-2 · 2021 · External reference

Prognostic value of 18F-FDG PET/CT-derived secondary lymphoid organ ratios and hematologic inflammation markers in advanced non-small cell lung cancer treated with nivolumab

10.3390/jcm15020798 · 2026 · External reference

Tumor metabolic and secondary lymphoid organ metabolic markers on 18F-fludeoxyglucose positron emission tomography predict prognosis of immune checkpoint inhibitors in advanced lung cancer

10.3389/fimmu.2022.1004351 · 2022 · External reference

Prognostic significance of diffuse increased fluorine-18-fluorodeoxyglucose uptake within the reticuloendothelial system in lym-phoma patients

10.21037/qims-24-180 · 2024 · External reference

Prognostic value of diffusely increased FDG uptake in spleen and/or bone marrow due to reticuloendothelial system activation in lymphoma patients

10.1186/s12885-026-15568-4 · 2026 · External reference

10.1002/cam4.70650

10.1002/cam4.70650 · External reference

Total metabolic tumor volume and spleen metabolism on baseline [18F]-FDG PET/CT as inde-pendent prognostic biomarkers of recurrence in resected breast cancer

10.1007/s00259-021-05322-2 · 2021 · External reference

Relationship of FDG uptake of the reticuloendothelial system with tumor immune microenvironment and prognosis in patients with gastric cancer

10.3390/life13030771 · 2023 · External reference

10.1371/journal.pone.0196110

10.1371/journal.pone.0196110 · External reference

10.1097/00003072-199905000-00004

10.1097/00003072-199905000-00004 · External reference

10.1038/s41598-021-81298-1

10.1038/s41598-021-81298-1 · External reference

Systemic immunity in cancer

10.1038/s41568-021-00347-z · 2021 · External reference

Systemic dysfunction and plasticity of the immune macroenvironment in cancer models

10.1038/s41591-020-0892-6 · 2020 · External reference

0

10.1007/s00259-014-2961-x · 2015 · External reference